Showing results (81-90 of 97) with videos related to
Sort By:
Pageof 10
EJNMMI Research|November 25, 2023
Assessment of hypoxia and oxidative-related changes in a lung-derived brain metastasis model by [64Cu][Cu(ATSM)] PET and proteomic studiesJade Fantin, Jérôme Toutain, Elodie A Pérès, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 7, 2016
Carbogen-induced increases in tumor oxygenation depend on the vascular status of the tumor: A multiparametric MRI study in two rat glioblastoma modelsArarat Chakhoyan, Aurélien Corroyer-Dulmont, Marine M Leblond, et al.Molecular Medicine (Cambridge, Mass.)|August 2, 2008
Endogenous erythropoietin as part of the cytokine network in the pathogenesis of experimental autoimmune encephalomyelitisManuela Mengozzi, Ilaria Cervellini, Paolo Bigini, et al.Neuro-Oncology|September 21, 2019
VCAM-1 targeted alpha-particle therapy for early brain metastasesAurélien Corroyer-Dulmont, Samuel Valable, Nadia Falzone, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 20, 2017
[18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesisLien Bekaert, Samuel Valable, Emmanuèle Lechapt-Zalcman, et al.Frontiers in Oncology|September 10, 2021
Radioimmunotherapy for Brain Metastases: The Potential for Inflammation as a Target of ChoiceAurélien Corroyer-Dulmont, Cyril Jaudet, Anne-Marie Frelin, et al.Biomaterials|August 3, 2020
Nanosized zeolites as a gas delivery platform in a glioblastoma modelClément Anfray, Sarah Komaty, Aurélien Corroyer-Dulmont, et al.Theranostics|January 2, 2018
Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastasesNadia Falzone, Nicole L Ackerman, Liset de la Fuente Rosales, et al.Neuro-Oncology|November 2, 2012
Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacyAurélien Corroyer-Dulmont, Elodie A Pérès, Edwige Petit, et al.International Journal of Molecular Sciences|December 28, 2019
Hadrontherapy Interactions in Molecular and Cellular BiologyJuliette Thariat, Samuel Valable, Carine Laurent, et al.Pageof 10